Bleeding Edge

The Bleeding Edge is the only free newsletter that features investing insights from editor Colin Tedards. Here, Colin will share what he's watching in the market and which stocks you'll want on your radar.



The Biotech Stock on My Buy List

Biotech giant Moderna’s stock traded flat for much of 2019. But then in late February, the pandemic changed everything – and it suddenly thrust Moderna and a handful of essential biotech stocks into the national spotlight…

We’re in Phase 2 of the 5G Rollout

Once every 10 years, the world goes through a major wireless infrastructure build-out. In the 2020s, it has been the revolutionary build-out of 5G wireless networks. And now we’re firmly in the next profitable phase of 5G adoption…